PATENT CLAIM ANALYSIS

Application Number: 15937496
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-04
Patent Classification: ["514", "002400"]

Abstract:
Sulfanyl-tetrahydropyran-based compounds, pharmaceutical compositions comprising them, and methods of their use for the treatment of diseases and disorders such as diabetes and obesity are disclosed.

Claim (Index 26):
A method of inhibiting sodium glucose co-transporter 2 activity, which comprises contacting sodium glucose co-transporter 2 with an effective amount of a compound of  claim 1 .

Metadata:
- Claim Count in Document: 3.0
- Percentile: 90.0
- Lexical Diversity: 1.16667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12041860', '12858666', '11862690', '14082786', '13925981']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8214385030226306
- 35 USC 102 Novelty (BERT): 0.6368684241857506
- Combined Prediction Score: 0.8029814951389426
- Mean Citation Score: 501.768728
- Max Citation Score: 581.3088
- Similarity Product: 562.0662261554719

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test